SLC22A6 and Hodgkins lymphoma: The drug interaction involving hOAT1 (SLC22A6) and hOAT3 (SLC22A8), responsible for renal tubular methotrexate secretion, has also been described in a Japanese patient with Hodgkin’s disease [70].